Oxford University To Study Mixing COVID-19 Vaccines

The video discusses the possibility of mixing COVID-19 vaccine doses from different companies, a question many have asked. Oxford University is conducting trials to assess the safety and effectiveness of combining Pfizer and AstraZeneca vaccines. If successful, this approach could alleviate supply issues and help more people get vaccinated.

What is the main question researchers are trying to answer in the study?

• Whether mixing vaccine doses is more effective than single doses

• If receiving doses from different companies is safe

• The cost-effectiveness of different vaccines

• How long the immunity lasts after vaccination

Which institution is leading the trial on vaccine combinations?

• Cambridge University

• Oxford University

• Stanford University

• Harvard University

What are the two vaccines being combined in the trial?

• Moderna and Johnson & Johnson

• Pfizer and AstraZeneca

• Sinovac and Sputnik V

• Covaxin and Novavax

What is the third group in the trial receiving?

• A single dose of a vaccine

• A combination of three different vaccines

• Two doses of the same vaccine

• A placebo

How could the study potentially benefit communities?

• By increasing the speed of vaccine production

• By eliminating the need for booster shots

• By helping more people get vaccinated despite supply issues

• By reducing the cost of vaccines